Cited 0 time in
Inhibition of Mortalin Leads to Anti-Fibrosis and Apoptosis of the Keloid Spheroid
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Ahn, Hyo Min | - |
| dc.contributor.author | Lee, Won Jai | - |
| dc.contributor.author | Na, Youjin | - |
| dc.contributor.author | Wadhwa, Renu | - |
| dc.contributor.author | Hong, JinWoo | - |
| dc.contributor.author | Yun, Chae-Ok | - |
| dc.date.accessioned | 2021-08-02T13:30:21Z | - |
| dc.date.available | 2021-08-02T13:30:21Z | - |
| dc.date.created | 2021-05-11 | - |
| dc.date.issued | 2018-05 | - |
| dc.identifier.issn | 1525-0016 | - |
| dc.identifier.uri | https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/17013 | - |
| dc.description.abstract | Mortalin is a mitochondrial chaperone of the heat shock protein 70 family and it’s pro-proliferative and anti-apoptosis functions could be associated with keloid pathogenesis, and blocking of mortalin and its interaction with p53 might be a potential novel target for the treatment of keloid. Therefore, we generated mortalin-specific small hairpin (sh) RNAs (dE1-RGD/GFP/shMot) and introduced into keloid spheroids for examination of its apoptotic and anti-fibrotic effect. On keloid tissues, mortalin expression was higher than adjacent normal tissues and it’s protein expressions were activated keloid fibroblasts (KFs). After primary keloid spheroid were transduced with dE1-RGD/GFP/shMot for knockdown of mortalin, expression of type I, III collagen, fibronectin, and elastin was significantly reduced and transforming growth factor-ß1, epidermal growth factor receptor (EGFR), Extracellular Signal-Regulated Kinases 1 and 2 (Erk 1/2), and Smad 2/3 complex protein expression were decreased. In addition, increased TUNEL activities and cytochrome C were bserved. Further, for examine of mortalin and p53 interaction, we performed immunofluorescence analysis. Knockdown of mortalin relocated p53 to the cell nucleus in primary keloid spheroids by dE1-RGD/GFP/shMot transduction. These results support the utility of knockdown of mortalin to induce apoptosis and reduce ECMs expression in keloid spheroid, which may be highly beneficial in treating keloids. | - |
| dc.language | 영어 | - |
| dc.language.iso | en | - |
| dc.publisher | CELL PRESS | - |
| dc.title | Inhibition of Mortalin Leads to Anti-Fibrosis and Apoptosis of the Keloid Spheroid | - |
| dc.type | Article | - |
| dc.contributor.affiliatedAuthor | Yun, Chae-Ok | - |
| dc.identifier.doi | 10.1016/j.ymthe.2018.05.001 | - |
| dc.identifier.wosid | 000435342204153 | - |
| dc.identifier.bibliographicCitation | MOLECULAR THERAPY, v.26, no.5, pp.333 - 333 | - |
| dc.relation.isPartOf | MOLECULAR THERAPY | - |
| dc.citation.title | MOLECULAR THERAPY | - |
| dc.citation.volume | 26 | - |
| dc.citation.number | 5 | - |
| dc.citation.startPage | 333 | - |
| dc.citation.endPage | 333 | - |
| dc.type.rims | ART | - |
| dc.type.docType | Meeting Abstract | - |
| dc.description.journalClass | 1 | - |
| dc.description.isOpenAccess | Y | - |
| dc.description.journalRegisteredClass | scie | - |
| dc.relation.journalResearchArea | Biotechnology & Applied Microbiology | - |
| dc.relation.journalResearchArea | Genetics & Heredity | - |
| dc.relation.journalResearchArea | Research & Experimental Medicine | - |
| dc.relation.journalWebOfScienceCategory | Biotechnology & Applied Microbiology | - |
| dc.relation.journalWebOfScienceCategory | Genetics & Heredity | - |
| dc.relation.journalWebOfScienceCategory | Medicine, Research & Experimental | - |
| dc.identifier.url | https://www.sciencedirect.com/science/article/pii/S1525001618302041?via%3Dihub | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
222, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Korea+82-2-2220-1366
COPYRIGHT © 2024 HANYANG UNIVERSITY.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.
